Questions 31-33: Number of C antigens provided

Indicate if one or two HLA-C antigens were tested. If one antigen was tested, report the first antigen specificity in question 32 and continue with question 34.

If two antigens were tested, report the first antigen specificity in question 32 and the second antigen specificity in question 33. Continue with question 34.

Question 34: Specificity Bw4 present?

Bw4 refers to an epitope expressed by HLA-B alleles; epitopes are presented on the surface of the antigen and are recognized by the immune system. Bw4 and Bw6 are mutually exclusive and may confer reactivity with lymphocytes. Select “yes” if Bw4 specificity is present. Leave blank if specificity for Bw4 was not tested.

Question 35: Specificity Bw6 present?

Bw6 refers to an epitope expressed by HLA-B alleles; epitopes are presented on the surface of the antigen and are recognized by the immune system. Bw4 and Bw6 are mutually exclusive and may confer reactivity with lymphocytes. Select “yes” if Bw6 specificity is present. Leave blank if specificity for Bw6 was not tested.

Questions 36-38: Number of DR antigens provided

Indicate if one or two HLA-DR antigens were tested. If one antigen was tested, report the first antigen specificity in question 37 and continue with question 39.

If two antigens were tested, report the first antigen specificity in question 37 and the second antigen specificity in question 38. Continue with question 39.

Question 39: Specificity DR51 present?

HLA-DR51 is an HLA-DR variant that recognizes antigens from HLA-DRB5. Select “yes” if DR51 specificity is present. Leave blank if specificity for DR51 was not tested.

Question 40: Specificity DR52 present?

HLA-DR52 is an HLA-DR variant that recognizes antigens from HLA-DRB3. Select “yes” if DR52 specificity is present. Leave blank if specificity for DR52 was not tested.

Question 41: Specificity DR53 present?

HLA-DR53 is an HLA-DR variant that recognizes antigens from HLA-DRB4. Select “yes” if DR53 specificity is present. Leave blank if specificity for DR53 was not tested.

Questions 42-44: Number of DQ antigens provided

Indicate if one or two HLA-DQ antigens were tested. If one antigen was tested, report the first antigen specificity in question 43 and continue with question 45.

If two antigens were tested, report the first antigen specificity in question 43 and the second antigen specificity in question 44. Continue with question 45.

Questions 45-47: Number of DP antigens provided

Indicate if one or two HLA-DP antigens were tested. If one antigen was tested, report the first antigen specificity in question 46 and continue with the signature section.

If two antigens were tested, report the first antigen specificity in question 46 and the second antigen specificity in question 47. Continue with the signature section.

Signature
The FormsNet3SM application will automatically populate the signature data fields, including name and email address of person completing the form, and date upon submission of the form.

Last modified: Jan 27, 2020

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.